Information and data management are essential to support the collaborative and interdisciplinary pursuits of an academic veterinary medicine enterprise, ranging from research conducted by individual investigators, education processes, clinical care, and outreach to administration and management. Informatics is an academic discipline that focuses on the creation, management, storage, retrieval, and use of information and data and how technology can be applied to improve access to and use of these resources. In this article, we discuss the challenges in integrating informatics across a large academic enterprise from a veterinary medicine point of view. As a case study, we describe an example program of informatics at the University of Minnesota designed to support interdisciplinary collaboration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3138/jvme.38.1.5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Insulin degludec 100 U/mL for treatment of spontaneous diabetes mellitus in dogs.
J Vet Intern Med
January 2025
Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
Background: The advantages of insulin degludec 100 U/mL (IDeg100) in the treatment of diabetes mellitus (DM) include consistent release, predictable glucose-lowering effect, and minimal day-to-day variability.
Hypothesis/objectives: To describe the use of IDeg100 in dogs with DM, level of diabetic control and adverse effects.
Animals: Thirty-three client-owned dogs with DM.
Antimicrobial stewardship: a definition with a One Health perspective.
NPJ Antimicrob Resist
May 2024
Ausvet Europe, Lyon, France.
Antimicrobial stewardship (AMS) is a commonly advocated approach to address antimicrobial resistance. However, AMS is often defined in different ways depending on where it is applied, such that a range of definitions is now in use. These definitions may be functional and well-structured for a given context but are often ill-adapted for collaborative work, creating difficulties for intersectoral communication on AMS and complicating the design, implementation, and evaluation of AMS interventions from a One Health perspective.
View Article and Find Full Text PDFDesign and Process Considerations for Preparation of Modified Release Ivermectin and Praziquantel Tablets by Wet Granulation.
AAPS PharmSciTech
January 2025
University of Maryland, School of Pharmacy, Department of Pharmaceutical Sciences, 20 N Pine Street, Baltimore, Maryland, 21201, USA.
Dosage forms containing Ivermectin (IVER) and Praziquantel (PRAZ) are important combination drug products in animal health. Understanding the relationship between products with differing in vitro release characteristics and bioequivalence could facilitate generics. The goal of this study was to create granulations for each active ingredient, with similar release mechanisms, but substantially different in vitro release rates, and then compressing these granulations into tablets with differing release rates.
View Article and Find Full Text PDFConference report of the 2024 Antimicrobial Resistance Meeting.
NPJ Antimicrob Resist
November 2024
Department of Genetics, University of Cambridge, Cambridge, United Kingdom.
Ameliorative effect of aqueous leaf extract of Pistacia lentiscus L. against oxaliplatin-induced hepatic injury, oxidative stress, and DNA damage in vitro and in vivo.
Med Oncol
January 2025
Laboratory of Molecular Toxicology, Faculty of Nature and Life Sciences, University of Jijel, 18000, Jijel, Algeria.
The current study aimed to assess the preventive effects of aqueous leaf extract of Pistacia lentiscus (ALEPL) against Oxaliplatin (OXA)-induced DNA damage, hepatic injury, and oxidative stress. The in vitro cytotoxic and genotoxic effects of OXA and ALEPL on HCT116 colon cancer cells were evaluated using the MTT (Tetrazolium salt reduction) assay and comet assay. The in vivo study involved 24 female NMRI (Naval Medical Research Institute) mice that were equally divided into four groups as follows: Control group, ALEPL-treated group (100 mg/kg), OXA-treated group (7 mg/kg), and ALEPL-treated group (100mg/kg) + OXA (7mg/kg).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!